Accent’s Approach & Pipeline

Accent is taking a novel view of cancer – leveraging our industry-leading expertise in RNA-modifying protein (RMPs) biology. We look beyond mutation-specific vulnerabilities to identify and exploit critical intracellular dependencies that span multiple types of cancer and develop small molecule therapeutics designed to inhibit those targets and offer far-reaching potential for patients. Our approach has identified numerous high-value programs, both first-in-class and best-in-class, for which we strive to benefit large patient populations with significant unmet medical need.

5 parallel orange lines winding through circle containing up-close view of a cancer cell. Two small purple circles surround the main photo.
5 parallel orange lines winding through circle containing up-close view of a cancer cell. Two small purple circles surround the main photo.
Gray background with parallel blue lines weaving through circle containing a photo of an ACCENTuator in the lab. Two small orange circles surround the main photo.

Team

Our people are Accent. We are a highly experienced and collaborative team of ACCENTuators, all keenly focused on driving the translation of extraordinary science to life-changing therapies for patients.

Gray background with parallel blue lines weaving through circle containing a photo of an ACCENTuator in the lab. Two small orange circles surround the main photo.
3.21.24

Accent Therapeutics to Present Data Supporting DHX9 and KIF18A as Compelling Therapeutic Targets at American Association for Cancer Research (AACR) Annual Meeting 2024

1.23.24

Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies

Wave shape
Wave shape